• ABOUT NEWBRIDGE

    Our Business Network and Unique Value Proposition Provide a Platform to Bridge the Access Gap of Global Innovation Within MENA Region

     

  • 1

Immunology

CIMZIA® (certolizumab pegol) is a Tumor Necrosis Factor (TNF) blocker. Cimzia is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis; for the treatment of adult patients with active psoriatic arthritis; for the treatment of adult patients with active ankylosing spondylitis. 

*for full prescribing information please refer to your locally approved label*

 

Product

  • 1